150 related articles for article (PubMed ID: 11808937)
21. Evaluation of iron status in patients with chronic hepatitis C.
Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
[TBL] [Abstract][Full Text] [Related]
22. SEN virus infection influences the pathological findings in liver but does not affect the incidence of hepatocellular carcinoma in patients with chronic hepatitis C and liver cirrhosis.
Moriyama M; Mikuni M; Matsumura H; Nakamura H; Oshiro S; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Tanaka N; Arakawa Y
Liver Int; 2005 Apr; 25(2):226-35. PubMed ID: 15780043
[TBL] [Abstract][Full Text] [Related]
23. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years.
Persico M; Perrotta S; Persico E; Terracciano L; Folgori A; Ruggeri L; Nicosia A; Vecchione R; Mura VL; Masarone M; Torella R
J Viral Hepat; 2006 May; 13(5):290-6. PubMed ID: 16637858
[TBL] [Abstract][Full Text] [Related]
25. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
26. Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin.
Hoofnagle JH; Ghany MG; Kleiner DE; Doo E; Heller T; Promrat K; Ong J; Khokhar F; Soza A; Herion D; Park Y; Everhart JE; Liang TJ
Hepatology; 2003 Jul; 38(1):66-74. PubMed ID: 12829988
[TBL] [Abstract][Full Text] [Related]
27. A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective study.
Elsebae MM; Abu-Zekri NB
Int J Surg; 2008 Oct; 6(5):362-6. PubMed ID: 18662898
[TBL] [Abstract][Full Text] [Related]
28. Iron overload and glucose abnormalities in chronic hepatitis C virus infection: phlebotomy lowers risk of new-onset diabetes.
Mifuji-Moroka R; Iwasa M; Miyachi H; Sugimoto R; Tanaka H; Ishihara T; Fujita N; Kaito M; Kobayashi Y; Takei Y
Hepatogastroenterology; 2013 Oct; 60(127):1736-41. PubMed ID: 24634944
[TBL] [Abstract][Full Text] [Related]
29. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
Moriyama M; Matsumura H; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Goto I; Tanaka N; Arakawa Y
Liver Int; 2005 Feb; 25(1):85-90. PubMed ID: 15698403
[TBL] [Abstract][Full Text] [Related]
30. Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy.
Taniguchi H; Iwasaki Y; Fujiwara A; Sakaguchi K; Moriya A; Yu PC; Takaki A; Fujioka S; Shimomura H; Shiratori Y
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):281-7. PubMed ID: 16460487
[TBL] [Abstract][Full Text] [Related]
31. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
[TBL] [Abstract][Full Text] [Related]
32. The advantage of gastrectomized patients in management of their chronic hepatitis C.
Hayashi H; Takikawa T; Arai N; Yano M
Nagoya J Med Sci; 1997 Nov; 60(3-4):119-27. PubMed ID: 9481091
[TBL] [Abstract][Full Text] [Related]
33. Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome.
Piperno A; Vergani A; Salvioni A; Trombini P; Viganò M; Riva A; Zoppo A; Boari G; Mancia G
Liver Int; 2004 Oct; 24(5):471-6. PubMed ID: 15482345
[TBL] [Abstract][Full Text] [Related]
34. Liver disease in chelated transfusion-dependent thalassemics: the role of iron overload and chronic hepatitis C.
Di Marco V; Capra M; Gagliardotto F; Borsellino Z; Cabibi D; Barbaria F; Ferraro D; Cuccia L; Ruffo GB; Bronte F; Di Stefano R; Almasio PL; Craxì A
Haematologica; 2008 Aug; 93(8):1243-6. PubMed ID: 18556410
[TBL] [Abstract][Full Text] [Related]
35. Role of iron in the natural history and clinical course of hepatitis C disease.
Shedlofsky SI
Hepatogastroenterology; 1998; 45(20):349-55. PubMed ID: 9638405
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
[TBL] [Abstract][Full Text] [Related]
37. Serum levels of intercellular adhesion molecule-1 and nitric oxide in patients with chronic hepatitis related to hepatitis C virus: connection fibrosis.
Pata C; Yazar A; Altintas E; Polat G; Aydin O; Tiftik N; Konca K
Hepatogastroenterology; 2003; 50(51):794-7. PubMed ID: 12828087
[TBL] [Abstract][Full Text] [Related]
38. Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels.
Zhu R; Huang H; Zhang H; Wang Z; Hu X; Zhai W; Lin Y; Wang J; Zhu H
Liver Int; 2006 Feb; 26(1):82-9. PubMed ID: 16420513
[TBL] [Abstract][Full Text] [Related]
39. The natural history of chronic hepatitis B: a retrospective study.
Wu GC; Zhou WP; Zhao YR; Guo SH; Wang ZY; Zou SB; Zhang QH; Ren H; Huang AL; Zhang DF
Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):566-70. PubMed ID: 14627521
[TBL] [Abstract][Full Text] [Related]
40. Assessment of iron metabolism in children with chronic hepatitis B -- prognostic factor in interferon alpha therapy.
Chrobot A; Chrobot AM; Szaflarska-Szczepanik A
Med Sci Monit; 2002 Apr; 8(4):CR269-73. PubMed ID: 11951069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
